These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29356833)

  • 21. Long-term safety and efficacy of adalimumab in Japanese patients with moderate to severe Crohn's disease.
    Watanabe M; Hibi T; Mostafa NM; Chao J; Arora V; Camez A; Petersson J; Thakkar R
    J Crohns Colitis; 2014 Nov; 8(11):1407-16. PubMed ID: 24874893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment with immunosupressants in a patient with Crohn's disease and common variable immunodeficiency].
    Trigo Salado C; Leo Carnerero E; Pizarro Moreno Á; de la Cruz Ramírez MD; Araujo Miguez Á; Herrera Justiniano JM; Márquez Galán JL
    Gastroenterol Hepatol; 2015 Nov; 38(9):544-5. PubMed ID: 25454598
    [No Abstract]   [Full Text] [Related]  

  • 23. Adalimumab versus azathioprine to halt the progression of bowel damage in Crohn's disease: application of Lémann Index.
    Ribaldone DG; Caviglia GP; Pellicano R; Vernero M; Italia A; Morino M; Saracco GM; Astegiano M
    Scand J Gastroenterol; 2019 Nov; 54(11):1339-1345. PubMed ID: 31692395
    [No Abstract]   [Full Text] [Related]  

  • 24. A case of molluscum contagiosum infection in a patient with Crohn's disease, receiving combination therapy with azathioprine and adalimumab.
    Cintolo M; Guarneri C; Lentini M
    J Crohns Colitis; 2015 Jul; 9(7):593-4. PubMed ID: 25908722
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparative effectiveness of immunosuppressants and biologics for inducing and maintaining remission in Crohn's disease: a network meta-analysis.
    Hazlewood GS; Rezaie A; Borman M; Panaccione R; Ghosh S; Seow CH; Kuenzig E; Tomlinson G; Siegel CA; Melmed GY; Kaplan GG
    Gastroenterology; 2015 Feb; 148(2):344-54.e5; quiz e14-5. PubMed ID: 25448924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe Necrotising Toxoplasmic Retinochoroiditis in a Patient With Crohn's Disease in Use of Adalimumab and Azathioprine.
    Biancardi AL; Costa JB; de Azevedo LGB; de Moraes HV; Barroso PF; Zaltman C
    Inflamm Bowel Dis; 2020 Jun; 26(7):e69-e70. PubMed ID: 32415301
    [No Abstract]   [Full Text] [Related]  

  • 27. Early combined immunosuppression in Crohn's disease.
    Badina L; Taddio A; Ventura A
    Lancet; 2008 Jun; 371(9629):1995; author reply 1996-7. PubMed ID: 18555906
    [No Abstract]   [Full Text] [Related]  

  • 28. Hidradenitis suppurativa in Crohn's disease during adalimumab therapy: a paradox?
    Martina E; Campanati A; Giuliodori K; Offidani A
    Acta Dermatovenerol Alp Pannonica Adriat; 2017 Mar; 26(1):21-23. PubMed ID: 28352932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pneumocystis jiroveci (carinii) pneumonia following initiation of infliximab and azathioprine therapy in a patient with Crohn's disease.
    Seddik M; Meliez H; Seguy D; Viget N; Cortot A; Colombel JF
    Inflamm Bowel Dis; 2004 Jul; 10(4):436-7. PubMed ID: 15475754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of adalimumab in patients with Crohn's disease and failure to infliximab therapy: a clinical series.
    Cordero Ruiz P; Castro Márquez C; Méndez Rufián V; Castro Laria L; Caunedo Álvarez A; Romero Vázquez J; Herrerías Gutiérrez JM
    Rev Esp Enferm Dig; 2011 Jun; 103(6):294-8. PubMed ID: 21736395
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypersensitivity to azathioprine in a patient with Crohn's disease: a case report.
    Sousa M; Proença L; Carvalho J
    Rev Esp Enferm Dig; 2017 Oct; 109(10):735. PubMed ID: 28929775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [From research to clinic: The case of Crohn's disease and Tumor Necrosis Factor].
    Pellicano R
    Minerva Gastroenterol Dietol; 2000 Jun; 46(2):131-8. PubMed ID: 19320082
    [No Abstract]   [Full Text] [Related]  

  • 33. Varicella Complicated by Severe Pneumonia and Shock in an Immunosuppressed Crohn's Disease Patient Under Azathioprine and Anti-Tumour Necrosis Factor Alpha.
    Abreu C; Santos L; Magro F
    J Crohns Colitis; 2015 Dec; 9(12):1176-8. PubMed ID: 26351378
    [No Abstract]   [Full Text] [Related]  

  • 34. Fatal Epstein-Barr virus primo infection in a 25-year-old man treated with azathioprine for Crohn's disease.
    N'guyen Y; Andreoletti L; Patey M; Lecoq-Lafon C; Cornillet P; Léon A; Jaussaud R; Fieschi C; Strady C
    J Clin Microbiol; 2009 Apr; 47(4):1252-4. PubMed ID: 19193838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adalimumab trough levels predict Crohn's disease clinical course.
    Ribaldone DG; Manetta T; Mengozzi G; Saracco GM; Pellicano R; Astegiano M
    Dig Liver Dis; 2018 Feb; 50(2):204-206. PubMed ID: 29129478
    [No Abstract]   [Full Text] [Related]  

  • 36. Pneumocystosis in a patient with Crohn's disease treated with combination therapy with adalimumab.
    Desales AL; Mendez-Navarro J; Méndez-Tovar LJ; Ortiz-Olvera NX; Cullen G; Ocampo J; Lemus W; Tun AE; Mayoral-Zavala A; Dehesa-Violante M
    J Crohns Colitis; 2012 May; 6(4):483-7. PubMed ID: 22398055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crohn's-like disease in a patient with common variable immunodeficiency treated with azathioprine and adalimumab.
    Vázquez-Morón JM; Pallarés-Manrique H; Martín-Suárez IJ; Benítez-Rodríguez B; Ramos-Lora M
    Rev Esp Enferm Dig; 2013; 105(5):299-302. PubMed ID: 23971663
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adalimumab dose escalation and dose de-escalation success rate and predictors in a large national cohort of Crohn's patients.
    Baert F; Glorieus E; Reenaers C; D'Haens G; Peeters H; Franchimont D; Dewit O; Caenepeel P; Louis E; Van Assche G;
    J Crohns Colitis; 2013 Mar; 7(2):154-60. PubMed ID: 22537637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Predictors of efficacy, mucosal healing and dose intensification during the first year of adalimumab therapy in patients with luminal and fistulizing Crohn's disease. National data from Hungary].
    Kiss LS; Szamosi T; Molnár T; Miheller P; Lakatos L; Vincze A; Palatka K; Bartha Z; Gasztonyi B; Salamon A; Horváth G; Tóth GT; Farkas K; Banai J; Tulassay Z; Nagy F; Szenes M; Veres G; Lovász BD; Végh Z; Golovics PA; Szathmári M; Papp M; Lakatos PL
    Orv Hetil; 2011 Sep; 152(36):1433-42. PubMed ID: 21865144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.